FindTrial
Sign In

Evaluation of the clinical efficacy of oseltamivir in the treatment of influenza-like illnesses patients: a case records based retrospective study

Epidemiological and disease burden survey of influenza patients in fever clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022708
Enrollment
Unknown
Registered
2019-04-23
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Two groups:oseltamivir's 75mg Bid and supportive therapy versus supportive therapy

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: fever 38 degree C or higher, cough or sore throat, course of 3 days or less.

Exclusion criteria

Exclusion criteria: 1. Lack of follow-up results; 2. Incomplete medical records.

Design outcomes

Primary

MeasureTime frame
recovery days of temperature;—

Secondary

MeasureTime frame
Recovery days of cough;—

Contacts

Public ContactLi Xiaoguang

Peking University Third Hospital

caitlin901@163.com+86 010-82265599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026